Exiqon has introduced the third generation of its microRNA qPCR focus panel for preclinical toxicology research.
The panel allows researchers conducting toxicology and organ injury studies to analyze a panel of selected miRNAs in biofluids, according to the company. A complete panel of 87 validated miRNA assays is available for human, rat, monkey, and dog.